Poster
22 March 2024 Synergistic killing of Staphylococcus aureus by the combination of cold atmospheric plasma and antimicrobial blue light
Gizem Dilara Ozdemir, Carolina dos Anjos, Utku Kursat Ercan, Tianhong Dai
Author Affiliations +
Conference Poster
Abstract
This study investigated the potential of an innovative combinational therapy utilizing antimicrobial blue light (aBL) and cold atmospheric plasma (CAP) against Staphylococcus aureus, a clinically challenging gram-positive bacterium. For planktonic S. aureus, sequential treatment (1-3 min CAP followed by 270 J/cm2 aBL) demonstrated an increase of 3- to 6- log10CFU reduction compared to aBL alone, while simultaneous treatment (concurrent 90 J/cm2 aBL and 25 min CAP) led to an increase of 7-log10CFU reduction. For biofilms, a remarkable CFU reduction of 6.5- to 7- log10 was observed for sequential treatment (3-5 min CAP followed by 432 J/cm2 aBL) and a 3-log10CFU reduction for simultaneous treatment (concurrent application 108 J/cm2 aBL and 30 min CAP). These findings highlight the unprecedented efficacy of the aBL + CAP combinational therapy in enhancing the potency against S. aureus, offering a promising approach to overcome antibiotic resistance.
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Gizem Dilara Ozdemir, Carolina dos Anjos, Utku Kursat Ercan, and Tianhong Dai "Synergistic killing of Staphylococcus aureus by the combination of cold atmospheric plasma and antimicrobial blue light", Proc. SPIE PC12822, Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2024, PC128220U (22 March 2024); https://doi.org/10.1117/12.3001824
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Atmospheric plasma

Biofilms

Resistance

Biomedical applications

Luminescence

Plasma treatment

Back to Top